Snow Capital Management’s AbbVie ABBV Stock Holding History

Snow Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$4.79M	Buy	42,495 +9,259	+28%	+$1.04M	0.68%	48
2021 Q1	$3.6M	Sell	33,236 -273	-0.8%	-$29.2K	0.52%	56
2020 Q4	$3.59M	Sell	33,509 -53	-0.2%	-$5.09K	0.61%	52
2020 Q3	$2.94M	Sell	33,562 -154	-0.5%	-$14.5K	0.59%	52
2020 Q2	$3.31M	Sell	33,716 -2,973	-8%	-$262K	0.69%	46
2020 Q1	$2.79M	Sell	36,689 -4,717	-11%	-$402K	0.64%	50
2019 Q4	$3.67M	Buy	41,406 +15,597	+60%	+$1.29M	0.51%	51
2019 Q3	$1.95M	Sell	25,809 -336,446	-93%	-$23.1M	0.14%	73
2019 Q2	$26.3M	Buy	+362,255	New	+$28.5M	1.73%	27

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Snow Capital Management's ABBV Position: Q2 2021 in Review

Snow Capital Management increased its AbbVie (ABBV) stake by 28% in Q2 2021, buying an estimated $1.04M and bringing the position to 42,495 shares worth $4.79M. The position accounts for 0.68% of the portfolio, ranked #48.

Snow Capital Management first reported a position in ABBV in Q2 2019 and has held it in 9 quarters since. The position peaked at $26.3M in Q2 2019. 2,677 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

Snow Capital Management held 42,495 shares of AbbVie worth $4.79M as of Q2 2021.
Snow Capital Management bought 9,259 AbbVie shares in Q2 2021, an estimated $1.04M.
AbbVie made up 0.68% of Snow Capital Management's portfolio in Q2 2021, its #48 holding.
Snow Capital Management first reported a position in AbbVie in Q2 2019 and has held it in 9 quarters since.
Snow Capital Management's AbbVie position peaked at $26.3M in Q2 2019.
2,677 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Snow Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.